Remedy Pharmaceuticals Lands New Round

  • Feed Type
  • Date
    2/10/2014
  • Company Name
    Remedy Pharmaceuticals
  • Mailing Address
    122 West 27th Street 10th Floor New York, NY 10001
  • Company Description
    Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury.
  • Website
    http://www.remedypharmaceuticals.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Funds will be used to accelerate Remedy’s GAMES-RP clinical trial of its central nervous system drug RP-1127.
  • M&A Terms
  • Venture Investor
    Broadview Ventures